Page last updated: 2024-08-23

paclitaxel and Erythroderma, Sezary

paclitaxel has been researched along with Erythroderma, Sezary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bates, SE; Fojo, T; Kayastha, GL; Piekarz, RL; Robey, RW; Zhan, Z1

Trials

1 trial(s) available for paclitaxel and Erythroderma, Sezary

ArticleYear
Increased MDR1 expression in normal and malignant peripheral blood mononuclear cells obtained from patients receiving depsipeptide (FR901228, FK228, NSC630176).
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Mar-01, Volume: 12, Issue:5

    Topics: Acetylation; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carcinoma, Renal Cell; Colonic Neoplasms; Depsipeptides; Didanosine; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Hippocalcin; Histones; Humans; Kidney; Kidney Neoplasms; Leukocytes, Mononuclear; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplastic Cells, Circulating; Paclitaxel; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sezary Syndrome; Tumor Cells, Cultured

2006